CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 57 enrolled
Drug / intervention
Ondansetron +1 moredrug
Likely dose
Ondansetron 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01841606
NCT01841606Phase 2Completed
CompareCT.gov

The Effect of Ondansetron on Cardiac Output in Elective Cesarean Deliveries Under Spinal Anesthesia: A Randomized Controlled Trial

University of British Columbia·interventional·Posted Apr 26, 2013·Updated May 11, 2018

In Brief

A Phase 2 clinical trial evaluating Ondansetron and Normal saline for Cardiac Output. Completed, enrolled 57 participants across 1 site.

Detailed Summary

Ondansetron is a medication routinely given to mothers having cesarean deliveries to help prevent and treat nausea and vomiting. The investigators are studying the hemodynamic effects of prophylactic ondansetron on parturients undergoing elective cesarean deliveries under spinal anesthesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Output
CountriesCanada
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2013
Enrollment StartMar 1, 2013
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.2 years ago

Interventions

Ondansetrondrug

4mg of IV ondansetron

Normal salineother

10mL of IV normal saline